調查指首季智利手機出貨量升71% 小米(01810.HK)出貨量增逾10倍市佔第三
調查機構Strategy Analytics發表指,智利首季智能手機出貨量按年大增71%至290萬台,破紀錄。期內小米(01810.HK)出貨量增逾10倍,市佔率16%排第三,該行預期到年底小米市佔有望升至第二位。
該行分析指出,儘管受疫情及政治不確定性影響,當地智能手機需求仍然強勁,主要受惠經濟上行、出口強勁及疫苗接種率較高,智利是拉丁美洲第三大智能手機市場,規模僅次於巴西及墨西哥。(el/k) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.